Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 2
1984 1
1985 1
1986 2
1987 1
1988 2
1989 3
1990 2
1991 4
1992 9
1993 4
1994 6
1995 4
1996 4
1997 2
1998 1
1999 4
2000 6
2001 9
2002 3
2003 15
2004 23
2005 36
2006 43
2007 26
2008 33
2009 36
2010 53
2011 64
2012 73
2013 69
2014 55
2015 69
2016 53
2017 75
2018 74
2019 65
2020 71
2021 82
2022 100
2023 80
2024 61
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,227 results

Results by year

Filters applied: . Clear all
Page 1
Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial.
Wang SL, Fang H, Song YW, Wang WH, Hu C, Liu YP, Jin J, Liu XF, Yu ZH, Ren H, Li N, Lu NN, Tang Y, Tang Y, Qi SN, Sun GY, Peng R, Li S, Chen B, Yang Y, Li YX. Wang SL, et al. Among authors: liu xf. Lancet Oncol. 2019 Mar;20(3):352-360. doi: 10.1016/S1470-2045(18)30813-1. Epub 2019 Jan 30. Lancet Oncol. 2019. PMID: 30711522 Clinical Trial.
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study.
Jin ZC, Chen JJ, Zhu XL, Duan XH, Xin YJ, Zhong BY, Chen JZ, Tie J, Zhu KS, Zhang L, Huang M, Piao MJ, Li X, Shi HB, Liu RB, Xu AB, Ji F, Wu JB, Shao GL, Li HL, Huang MS, Peng ZY, Ji JS, Yuan CW, Liu XF, Hu ZC, Yang WZ, Yin GW, Huang JH, Ge NJ, Qi X, Zhao Y, Zhou JW, Xu GH, Tu Q, Lin HL, Zhang YJ, Jiang H, Shao HB, Su YJ, Chen TS, Shi BQ, Zhou X, Zhao HT, Zhu HD, Ren ZG, Teng GJ; CHANCE2201 Investigators. Jin ZC, et al. Among authors: liu xf. EClinicalMedicine. 2024 May 6;72:102622. doi: 10.1016/j.eclinm.2024.102622. eCollection 2024 Jun. EClinicalMedicine. 2024. PMID: 38745965 Free PMC article.
Deep brain stimulation.
Chen XL, Xiong YY, Xu GL, Liu XF. Chen XL, et al. Among authors: liu xf. Interv Neurol. 2013 Sep;1(3-4):200-12. doi: 10.1159/000353121. Interv Neurol. 2013. PMID: 25187779 Free PMC article. Review.
2-Hydrazinyl-4-methyl-1,3-benzothia-zole.
Liu XF, Yu XY, Jiang SL. Liu XF, et al. Acta Crystallogr Sect E Struct Rep Online. 2011 Jul 1;67(Pt 7):o1641. doi: 10.1107/S1600536811020149. Epub 2011 Jun 11. Acta Crystallogr Sect E Struct Rep Online. 2011. PMID: 21837046 Free PMC article.
Coumarin derivatives with anticancer activities: An update.
Song XF, Fan J, Liu L, Liu XF, Gao F. Song XF, et al. Among authors: liu xf. Arch Pharm (Weinheim). 2020 Aug;353(8):e2000025. doi: 10.1002/ardp.202000025. Epub 2020 May 8. Arch Pharm (Weinheim). 2020. PMID: 32383190 Review.
1,227 results